| 产品描述: | Neuropeptide W-23 (human) (NPW-23), the active form of Neuropeptide W, is an endogenous agonist of NPBW1 (GPR7) and NPBW2 (GPR8) |
| 靶点: |
NPBW1, NPBW2 |
| 体内研究: |
Neuropeptide W-23 (human) (NPW-23) (0.3-3.0 nM; intracerebroventricular injection; 2 μL) increases total behavioral activity, including locomotion and grooming in conscious rats. Neuropeptide W-23 (human) (NPW-23) (2-8 nM; i.c.v.; 10 μL) shows anorexigenic effect in rats Animal Model: Male Harlan Sprague-Dawley rats, 250–300 g Dosage: 0.3, 1.0 and 3.0 nM Administration: Intracerebroventricular injection, 2 μL Result: Caused significant increases in mean arterial pressure. Demonstrated a significant increase in total activity, ambulatory activity, and duration of stereotypy. |
| 参考文献: |
1. Ji L, et al. Modulation of CaV1.2 calcium channel by neuropeptide W regulates vascular myogenic tone via G protein-coupled receptor 7. J Hypertens. 2015 Dec;33(12):2431-42. 2. Pate AT, et al. Neuropeptide W increases mean arterial pressure as a result of behavioral arousal. Am J Physiol Regul Integr Comp Physiol. 2013 Oct 1;305(7):R804-10. 3. Naso T, et al. Central neuropeptide W has anorexigenic effect in rats. J Anim Physiol Anim Nutr (Berl). 2014 Apr;98(2):228-34. |
| 溶解性: |
Soluble in H2O |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.387 ml |
1.935 ml |
3.87 ml |
| 5 mM |
0.077 ml |
0.387 ml |
0.774 ml |
| 10 mM |
0.039 ml |
0.193 ml |
0.387 ml |
| 50 mM |
0.008 ml |
0.039 ml |
0.077 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |